PHARMACEUTICAL DRUG DELIVERY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-170307 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Pharmaceutical Drug Delivery Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET
7.1 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Johnson & Johnson, Inc. (US)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 F. Hoffman-La Roche (Switzerland)
16.3 Merck & Co., Inc. (US)
16.4 Bayer AG (Germany)
16.5 Pfizer, Inc. (US)
16.6 Novartis AG (Switzerland)
16.7 3M Company (US)
16.8 Becton, Dickinson and Company (US)
16.9 GlaxoSmithKline plc, (UK)
16.10 Sanofi (France)
16.11 Antares Pharma, Inc. (US)
16.12 AbbVie (US)
16.13 Amgen (US)
16.14 Boehringer Ingelheim (Germany)
16.15 AstraZeneca (UK)
16.16 Eli Lilly and Company (US)
16.17 Gilead Sciences, Inc. (US)
16.18 Teva Pharmaceuticals (Israel)
16.19 Bristol-Myers Squibb (US)
16.20 Genmab A/S (Denmark)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Route of AdministrationOral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
By Application
Infectious Diseases
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Central Nervous System Disorders
Autoimmune Diseases
By Facility of Use
Hospitals
Home Care Settings
ASC/Clinics
Diagnostic Centers
Companies
Johnson & Johnson, Inc. (US)
F. Hoffman-La Roche (Switzerland)
Merck & Co., Inc. (US)
Bayer AG (Germany)
Pfizer, Inc. (US)
Novartis AG (Switzerland)
3M Company (US)
Becton, Dickinson and Company (US)
GlaxoSmithKline plc, (UK)
Sanofi (France)
Antares Pharma, Inc. (US)
AbbVie (US)
Amgen (US)
Boehringer Ingelheim (Germany)
AstraZeneca (UK)
Eli Lilly and Company (US)
Gilead Sciences, Inc. (US)
Teva Pharmaceuticals (Israel)
Bristol-Myers Squibb (US)
Genmab A/S (Denmark)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.